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Abstract
Background: Plasmodium falciparum contains three genes encoding potential glutamate dehydrogenases. The
protein encoded by gdha has previously been biochemically and structurally characterized. It was suggested that it
is important for the supply of reducing equivalents during intra-erythrocytic development of Plasmodium and,
therefore, a suitable drug target.
Methods: The gene encoding the NADP(H)-dependent GDHa has been disrupted by reverse genetics in P.
falciparum and the effect on the antioxidant and metabolic capacities of the resulting mutant parasites was
investigated.
Results: No growth defect under low and elevated oxygen tension, no up- or down-regulation of a number of
antioxidant and NADP(H)-generating proteins or mRNAs and no increased levels of GSH were detected in the
D10Δgdha parasite lines. Further, the fate of the carbon skeleton of [13C] labelled glutamine was assessed by
metabolomic studies, revealing no differences in the labelling of a-ketoglutarate and other TCA pathway
intermediates between wild type and mutant parasites.
Conclusions: First, the data support the conclusion that D10Δgdha parasites are not experiencing enhanced
oxidative stress and that GDHa function may not be the provision of NADP(H) for reductive reactions. Second, the
results imply that the cytosolic, NADP(H)-dependent GDHa protein is not involved in the oxidative deamination of
glutamate but that the protein may play a role in ammonia assimilation as has been described for other NADP(H)-
dependent GDH from plants and fungi. The lack of an obvious phenotype in the absence of GDHa may point to a
regulatory role of the protein providing glutamate (as nitrogen storage molecule) in situations where the parasites
experience a limiting supply of carbon sources and, therefore, under in vitro conditions the enzyme is unlikely to
be of significant importance. The data imply that the protein is not a suitable target for future drug development
against intra-erythrocytic parasite development.
Background
Glutamate dehydrogenases (GDH) are enzymes that cat-
alyse the reversible oxidative deamination of L-gluta-
mate to form a-ketoglutarate and ammonia using
NADP(H) or NAD(H) as co-factors:
α − ketoglutarate + NH3 + NAD(P)H L− glutamate + NAD(P)+
The enzymes are at the branch point of nitrogen and
carbon metabolism and either assimilate ammonia and
provide glutamate as nitrogen storage molecule or dis-
similate ammonia and provide a-ketoglutarate that can
feed into tricarboxylic acid (TCA) metabolism. There
are three different types of GDH depending on their co-
factor specificity. The enzymes specific for NAD(H) gen-
erally catalyse the oxidative deamination of L-glutamate
(to generate a-ketoglutarate) with an alkaline pH opti-
mum; the enzymes specific for NADP(H) usually carry
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out the reductive amination of a-ketoglutarate (to gen-
erate L-glutamate) with a neutral pH optimum. The
third type, represented by the vertebrate GDH enzymes,
can use both co-factors for the deamination of L-gluta-
mate [1].
The human malaria parasite Plasmodium falciparum
contains three genes encoding potential GDH proteins;
two are found on chromosome 14 (PF14_0164 and
PF14_0286, encoding GDHa and b, respectively) and
one is present on chromosome 8 (PF08_0132 encoding
GDHc) [2,3]. GDHa and GDHb are NADP(H)-depen-
dent and the primary sequence of GDHb suggests the
protein is located in the apicoplast, while the localisation
and co-factor specificity is not predictable for GDHc.
This presence of multiple GDH proteins is reminiscent
of plants and fungi [4-7]. In plants, the two NAD(H)-
dependent GDHs are essential for carbon metabolism
while the role of the putative NADP(H)-dependent
GDH is thought to provide glutamate through NH4
+
assimilation [7-10]. In fungi, the NADP(H) dependent
GDH are also involved in NH4
+ assimilation [4,5,11].
Plasmodium falciparum gdha was previously cloned
and recombinant protein was biochemically and structu-
rally characterized [3,12-14]. The kinetic parameters are
comparable to other GDH enzymes using NADP(H) as
co-factor and suggest that the enzyme catalyses both the
oxidative deamination of glutamate and the reductive
amination of a-ketoglutarate [13]. It was hypothesized
that one of the major roles of GDHa is to provide redu-
cing equivalents in form of NADPH that is required for
downstream redox reactions, carried out by the disul-
phide oxidoreductases glutathione reductase and thiore-
doxin reductase [14-17]. Thus, the enzyme was
considered integral to the parasite’s antioxidant machin-
ery and thought to be a potential drug target
[3,13,14,18,19]. Recently, it was shown that P. falci-
parum growth was susceptible to inhibition by the GDH
inhibitor, isophthalic acid. However, this effect was only
achieved at high μM concentrations suggesting that the
inhibitory effect may also be attributable to inhibition of
one or both of the other two GDH proteins [3]. A
recent high-throughput drug screen against several
potential drug targets for the development of Plasmo-
dium, which included GDHa, did not identify any speci-
fic compounds that were inhibitory for the enzyme,
questioning the suitability of GDHa as a drug target
because it may simply not be “druggable” [20].
To genetically validate GDHa as a potential target for
the design of new anti-malarials during their intra-ery-
throcytic development this study generated gdha null
mutants of P. falciparum and investigated their pheno-
types with respect to their abilities to withstand oxidative
challenges, their expression levels of antioxidant proteins
and the metabolic fate of isotope labelled glutamine.
Methods
Materials
WR99210 was a kind gift from Jacobus Pharmaceuticals
(USA). Plasmids pHH1 and pHH2 were kind gifts from
Professor A. F. Cowman (The Walter and Eliza Hall
Institute, Melbourne, Australia) [21,22]. Human blood
was obtained from the Glasgow blood transfusion ser-
vices. Specific antibodies, used in western blot experi-
ments, were generated in rabbit or rat using
recombinantly expressed protein [23-28] (Eurogentec,
Belgium). Secondary antibodies were obtained from Pro-
mega. Anti-GST antibodies were a kind gift from Pro-
fessor E. Liebau (University of Münster, Germany), anti-
SOD 1 and 2 were obtained from Dr J. Khalife (Univer-
sity of Lille Nord de France, Institut Pasteur de Lille,
France) and GDHa antibodies were a gift from Professor
L. Krauth-Siegel (University of Heidelberg, Germany).
[8-3H]-hypoxanthine (specific activity: 10-30 Ci/mmol)
was from American Radiolabeled Chemicals. U-[13C]
glutamine and U-[13C-15N] glutamine were purchased
from CK gas, UK. All other chemicals were purchased
from Sigma UK unless otherwise stated.
Knockout and expression constructs of P. falciparum gdha
The knockout and expression fragments of the P. falci-
parum gdha gene were amplified from P. falciparum
3D7 or D10 genomic DNA using Pfx Supermix (Invitro-
gen, UK). The specific oligonucleotide primers 5’-
GCGCAGATCTGGTTTACGATTTCATCC-3’ (sense)
and 5’-CGCGCTCGAG(TTA)TTGCTGCTTTTGA
TGG-3’ (antisense) with the BglII and XhoI restriction
sites, respectively, in bold, and an artificial stop codon
(in brackets) within the antisense oligonucleotide, were
used to generate the 841 bp insert equivalent to nucleo-
tides 339-1179 of the gdha open reading frame for the
gdha knockout construct. For the gdha-GFP construct
the primers 5’-GCGCAGATCT(ATG)AGTGCTCT-
TAAAG-3’ (sense) and 5’-CGCGCCTAGGAAAA-
CAACCTTG-3’ (anti sense) with the BglII and AvrII
restriction sites, respectively, in bold, and an artificial
start codon (in brackets) within the sense oligonucleo-
tide were used to generate a full-length protein with a
C-terminal GFP-tag. The PCR products were subcloned
into the TOPO-Blunt PCR cloning vector (Invitrogen)
and its sequences were verified (Eurofins MWG
Operon) before they were cloned into the P. falciparum
transfection plasmid pHH1 or pHH2, respectively, to
generate pHH1-Δgdha and pHH2-gdha-GFP.
Parasite culture, transfection, determination of IC50
values, and parasite growth rate
The P. falciparum D10 strain (Papua New Guinea) was
cultured according to Trager and Jensen [29] in RPMI
1640 (Invitrogen, UK) containing 11 mM glucose, 0.5%
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Albumax II (w/v) (Invitrogen, UK), 200 μM hypox-
anthine, 20 μg/ml gentamycin (PAA) in human erythro-
cytes between 0.5% and 5% haematocrit. Parasite
cultures were maintained under an atmosphere of
reduced oxygen (1% O2, 3% CO2 and 96% N2) and for
the growth experiment also at atmospheric oxygen with
5% CO2 at 37°C. Parasites were synchronized using sor-
bitol according to Lambros and Vanderberg [30] and
freed from erythrocytes using saponin according to
Umlas and Fallon [31]. Parasitaemia was determined
using Giemsa stained thin smears and the number of
live, isolated parasites was determined using a Neubauer
haemocytometer.
Transfection of pHH1-Δgdha and pHH2-gdha-GFP
into P. falciparum erythrocytic stages was performed as
described previously Crabb et al [32]. WR99210 resis-
tant parasites appeared between 25 and 60 days after
transfection. Parasites were cloned by limiting dilution
according to Kirkman et al [33].
The effects of N-methylphenazonium methosulfate,
tert-butylhydroperoxide and L-cycloserine on the viabi-
lity of P. falciparum erythrocytic stages were determined
by measuring the incorporation of [3H]-hypoxanthine in
the presence of increasing drug concentrations accord-
ing to Desjardins et al [34].
The growth rates of D10 and gdha null mutants
(D10Δgdha) were determined as described by Günther et
al [35]. Parasites were synchronized twice and after 24 h
diluted to 0.5% parasitaemia at 5% haematocrit. Giemsa
stained thin smears were prepared daily and parasitae-
mia determined by counting 1000 erythrocytes per
smear. The cultures were maintained at a suitable para-
sitaemia throughout the 6 day experiment by diluting
them 1:5 every second day.
Fluorescent microscopy
D10 transfected with pHH2-gdha-GFP, and resistant to
WR99210, at 10% parasitaemia were incubated for 5
min at 37°C with 25 nM MitoTracker Red and 100 μg/
ml Hoechst 33342 (both Invitrogen, UK), washed and
resuspended in warm complete medium. Cells were
viewed with the Applied Precision Deltavision Deconvo-
lution microscope system (Olympus IX-70 invert micro-
scope) fitted with a Coolsnap HQ camera and images
were processed with the SoftWoRx software.
Preparation of genomic DNA, RNA and protein from P.
falciparum
Parasites were released from erythrocytes by saponin
lysis and genomic DNA was isolated using the QIAamp
DNA Mini Kit (Qiagen, UK). RNA was extracted from
tightly synchronized trophozoites using TRIZOL
(Sigma) according to the manufacturer’s instructions
with modifications as described by Smith et al [36]. The
final RNA pellet was resuspended in 20-50 μl nuclease
free water and stored at -80°C. Protein extracts for wes-
tern blots were prepared by resuspending the parasite
pellets in lysis buffer (PBS, 0.5% (v/v) TritonX-100, 1
mM phenylmethylsulphonyl fluoride, 1 mM benzami-
dine, 20 μM leupeptin, 10 μM E-64, 2 μM 1,10-phenan-
throline, 4 μM pepstatin A) followed by three cycles of
freeze/thawing, a 15 min incubation on ice and 5 min
centrifugation at 17,000 g. For enzyme assays the para-
sites were lysed as above in 100 mM potassium phos-
phate buffer pH 7.0 in the presence of protease
inhibitors and centrifuged for 30 min at 17,000 g. Con-
centration of soluble protein was determined using the
Bradford assay with bovine serum albumin as a standard
[37].
Southern blotting
One to three μg of genomic DNA isolated from D10
and D10 transfected with pHH1-Δgdha were subjected
to digestion with NdeI overnight before the DNA was
separated on a 0.8% agarose gel and subsequently
blotted onto positively charged nylon membrane. After
cross-linking the DNA to the membrane, the blot was
prehybridized at 55°C before the probe (coding region
of the gdha gene) was added for an overnight incuba-
tion. The probe was prepared using the AlkPhos Direct
Labeling and Detection System (VWR, UK) and succes-
sive washes were performed according to the manufac-
turer’s instructions. The blot was exposed to
autoradiography film (Kodak) for 1 to 16 hours.
Western blotting
Ten μg of protein from D10, D10Δgdha-1 and D10Δgdha-2
were separated on 10% or 15% SDS-PAGE gels and
blotted onto nitrocellulose using a Transblot Semidry
transfer system (BioRad). The membranes were blocked
in 3% BSA in PBS (w/v) containing 0.5% Tween 20 (v/v)
at 4°C overnight before they were probed with the pri-
mary antibodies raised against P. falciparum GDHa
(1:2,000), P. falciparum glutathione S-transferase
(1:5,000), P. falciparum glutathione reductase
(1:100,000), P. falciparum superoxide dismutase 1 and 2
(1:5,000), P. falciparum 2Cys-peroxiredoxin 1 (1:
100,000), P. falciparum 1Cys-peroxiredoxin (1:100,000),
P. falciparum thioredoxin 1 (1:10,000) and P. falciparum
isocitrate dehydrogenase (1:30,000). Depending on the
respective size of the protein under investigation, an
antibody raised against P. falciparum branched chain
acyltransferase (BCDH-E2 at 1:5,000), detecting a pro-
tein of 50 kDa, or the P. falciparum 1Cys- peroxiredoxin
(25 kDa) antibody was used as loading control after it
was established that their expression was unchanged in
the parent and mutant parasites. The secondary anti-
rabbit or anti-rat (for SOD1 and 2 detection) HRP-
Storm et al. Malaria Journal 2011, 10:193
http://www.malariajournal.com/content/10/1/193
Page 3 of 12
conjugate antibodies were used at 1:10,000 dilution and
the signals were visualized using the Immobilon Wes-
tern kit (Millipore). Expression relative to the loading
control was analysed using LabImage 1D software
(Kapelan Bio-Imaging Solutions, Germany). The average
expression of the proteins was determined from 2 to 3
independent protein extracts.
Quantitative real-time PCR
RNA was isolated as described above and treated with
TURBO-DNA free (Ambion, UK) before synthesis of
cDNA with the RETROscript kit (Ambion, UK) follow-
ing manufacturer’s instructions. Real time PCR reactions
were performed in 25 μl using QuantiTect SYBR Green
master mix (Qiagen, UK) and primers at a final concen-
tration of 0.3 μM with the 7500 Real Time PCR system
(Applied Biosystems, UK). The transcription levels of
gdhb, gdhc, g-glutamylcysteine synthetase (ggcs), glu-
tathione synthetase (gs) and glucose-6 phosphate dehy-
drogenase (g-6pdh), were examined using the primer
pairs 5’-GCGTATGCAAAGAGAAGAGGAA-3’ and
5’-GTAGAAGTATAGCCGTAGTTGTGTA-3’ (gdhb),
5’-TCATCGTCTCCATCATCAGTTC-3’ and
5’-CTCACATTACTCTGAGCACATCT (gdhc),
5’-TCCTTGCTCTTACTGCATGTACT-3’ and
5’-TTCCGTTCTACAATCAACACTGT-3’ (ggcs),
5’-CTTTAGAGCATTATATACACCTAACCA-3’ and
5’-CGAACCAACAAGTTGATAAGGTA-3’ (gs),
5’-GACCTGAATGATTTTAATTGGAAAGCA-3’ and
5’-CATCTATCGGAGTTCGACCTC-3’ (g-6pdh).
Seryl-t-RNA synthase was used as endogenous control,
as it had been previously described to have a uniform
transcription pattern throughout the parasite life cycle
[38,39]. The primer pair
5’-AAGTAGCAGGTCATCGTGGTT-3’ and 5’-
TTCGGCACATTCTTCCATAA-3’ was used and the
efficiency of its amplification was similar to gdhb, gdhc,
ggcs, gs and g-6pdh. PCR cycling conditions were 50°C
for 2 min, 95°C for 15 min, followed by 40 cycles of 95°
C for 15 sec, 54°C for 30 sec and 68°C for 35 sec. Rela-
tive expression levels were calculated by the ΔΔCT
method (User Bulletin 2, Applied Biosystems, http://
www.appliedbiosystems.com).
GDH activity assays
GDHa activity was detected using a variation of the
MTT assay [40]. Five μg of purified recombinant GDHa
[3] and 10 μg of parasite extract was loaded onto 10%
polyacrylamide gel and resolved under non-denaturing
conditions. Gels were washed briefly in 100 mM potas-
sium phosphate buffer pH 8.0 containing 1 mM EDTA
and then incubated in the same buffer with 0.3 mg/ml
2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyltetrazolium
chloride, 0.03 mg/ml phenazine ethosulphate, with 100
mM L-glutamate and 1 mM NADP+ at 37°C, in the
dark, until the appearance of dark red coloured bands
(formazan deposits). The reaction was stopped by wash-
ing gels thoroughly with distilled water.
Total GDH activity was determined in parasite lysate
using a spectrophotometric assay based on the oxidation
of NAD(P)H or the reduction of NAD(P)+, respectively
[18]. The forward reaction contained 50 to 100 μg of
parasite lysate isolated from D10 or D10Δgdha-1 or
D10Δgdha-2, 10 mM a-ketoglutarate, 40 mM NH4Cl, 200
μM NADPH or NADH in 100 mM potassium phos-
phate buffer pH 7.0. The decrease in absorbance was
followed at 340 nm at 25°C (Uvikon 2501, Shimadzu).
The reverse reaction contained 100 μg of parasite
extract, 10 mM glutamate, 1 mM NADP+ or NAD+ in
100 mM potassium phosphate buffer pH 8.0. The
increase of absorbance was followed at 340 nm at 25°C.
The specific activity was determined using the molar
extinction coefficient of NAD(P)H of 6,220 M-1 cm-1 at
340 nm.
Glutathione determination
Glutathione (GSH) levels were determined by HPLC as
described by Williams et al [41]. Parasites were isolated
from 20 ml of tightly synchronized culture (~2 - 5 × 107
parasites) by saponin lysis, as described above, and para-
sites were incubated for 45 min at room temperature in
50 μl of 40 mM N-[2-hydroxyethyl]-piperazine-N’[3-
propanesulfonic acid], 4 mM diethylenetriamine penta-
acetic acid, pH 8.0, containing 0.7 mM tris(2-carbox-
yethyl)phosphine. 50 μl of 2 mM monobromobimane in
ethanol was added and samples heated to 70°C for 3
min before extracts were deproteinized for 30 min on
ice by addition of 100 μl 4 M methanesulfonic acid, pH
1.6. Precipitated protein was removed by centrifugation
for 40 min at 13,000 g at 4°C and the supernatant was
analysed by HPLC as described by Williams et al [41].
Metabolic labelling and mass spectrometry
Parasites were synchronized twice, 4 hours apart, and
after 35 hours washed in glutamine-free medium and
diluted to 7% parasitaemia and 0.7% haematocrit in
medium containing 2 mM U-[13C] glutamine or U-[13C-
15N] glutamine. At this stage the parasites are early
rings and after 32 hours (within 1 cycle) the metabolites
from the medium and red blood cells were extracted
with 80% methanol on dry ice, as described by Ols-
zewski et al [42]. Uninfected red blood cells were incu-
bated in standard culture medium at 5% haematocrit at
37°C for 20 hours prior to the metabolic labelling, as
described above, to activate their metabolism. The meta-
bolites were analysed by LC-MS using a Synergy Hydro-
RP column (Phenomenex, UK) and an Exactive orbitrap
mass spectrometer (Thermo Fisher Scientific, UK) and
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RAW files were converted and loaded into MAVEN, as
detailed by Olszewski et al [42].
Data analysis
Experiments were performed at least in duplicate using
independent parasite preparations. Graphs were gener-
ated and statistical analyses performed using GraphPad
Prism version 5 for Windows (GraphPad Software, San
Diego California USA). Significance between the
D10Δgdh clones and D10 was tested using ANOVA with
Newman Keuls post test. The IC50 values were calcu-
lated by non linear regressing of the sigmoidal dose-
response equation (GraphPad Software). Densitometry
of protein expression was analysed using LabImage 1D
software (Kapelan Bio-Imaging Solutions, Germany).
Results
Localization of GDHa in P. falciparum
The location of GDHa was assessed by expressing the
coding region of gdha, C-terminally tagged with green
fluorescent protein (GFP), from an episome in P. falci-
parum D10 intra-erythrocytic stages. Live parasites were
incubated with the nuclear stain Hoechst 33342 and the
mitochondrial stain MitoTracker Red and microscopy
revealed that the GFP-fusion protein was present exclu-
sively in the cytosol of the parasites (Figure 1).
Disruption of gdha in P. falciparum
The D10 strain of P. falciparum was used to disrupt the
gdha gene locus using the plasmid pHH1-Δgdha by sin-
gle cross-over homologous recombination (Figure 2A).
The Southern blot shows that upon diagnostic digest of
genomic DNA, isolated from D10, D10Δgdh and the
clones D10Δgdh-1 and D10Δgdh-2, the banding pattern
obtained with a gdha-specific probe is consistent with a
disruption of the gdha locus by the transfected plasmid
pHH1-Δgdha (Figure 2B). The gdha band characteristic
for the endogenous gene locus (5.3 kb) had disappeared
in the cloned parasite lines, while the diagnostic bands
for integration of the transfected plasmid into the gdha
gene locus were present (4.0 kb and 7.2 kb). Addition-
ally, the cloned parasite lines still maintained the
transfected plasmid (5.8 kb). D10Δgdh-1 and D10Δgdh-2
no longer expressed the GDHa protein (49.5 kDa) as
shown by western blotting using a GDHa-specific poly-
clonal antiserum. A non-specific 32 kDa protein is also
detected, which serves as a loading control for the para-
site extracts and verifies that equal amounts of protein
are present in all three lanes of the blot (Figure 2C).
The D10Δgdha clones also no longer displayed GDHa
enzymatic activity as assessed by an in-gel activity assay.
Purified recombinant GDHa was used as a control to
verify that the reaction band detected in the parasite
lysate was the result of GDHa activity (Figure 2D).
Clones D10Δgdh-1 and D10Δgdh-2 were used for further
analyses.
Determination of total GDH activity in D10, D10Δgdh-
1 and D10Δgdh-2 showed that the majority of NADPH
utilising activity is attributable to GDHa, as this activity
is no longer detectable when the GDHa function is lost.
The GDH activity of D10 was 36.9 ± 0.35 nmol/min/mg
protein while the activity of D10Δgdh-1 and D10Δgdh-2
was less than 10 nmol/min/mg protein, which was the
detection limit of the assay system when 100 μg protein
was used. It was only possible to determine the specific
activity of the forward reaction for GDH, as the reverse
reaction was also below the detection limit at these pro-
tein concentrations. The NADH-dependent reduction of
a-ketoglutarate also seemed affected in D10Δgdh-1 and
D10Δgdh-2 (10.6 ± 4.1 nmol/min/mg protein and 10.7 ±
4.1 nmol/min/mg protein, respectively) compared to
D10 parasites (20.1 ± 0.5 nmol/min/mg protein) sug-
gesting that the NADH-dependent GDH activity is still
present in the mutant parasite lines, albeit at lower
levels.
Growth of P. falciparum D10Δgdha and susceptibility to
elevated oxidative stress
The effect of low (1%) and high oxygen tension (20%)
on the growth rate of D10Δgdh-1 and D10Δgdh-2 was
assessed and compared to that of D10 parasites. The
absence of GDHa had no effect on the growth of
D10Δgdh-1 and D10Δgdh-2 under low oxygen or elevated
oxygen tension (Figure 3). This is surprising because it
was previously suggested that GDHa is important for
the generation of NADPH, which is required for the
parasite’s antioxidant defence [13,17]. To test this
hypothesis further, it was assessed whether D10Δgdh-1
and D10Δgdh-2 showed an increased susceptibility
towards exogenous or endogenous oxidative stress.
However, the IC50 values for N-methylphenazonium
methosulphate and tert-butylhydroperoxide determined
for D10Δgdh-1 and D10Δgdh-2 were similar to those of
the D10 wild type parasites (Table 1). These data do not
corroborate the hypothesis that GDHa is crucial for a
functional antioxidant defence of the parasites.
Figure 1 Cytosolic localization of GDHa D10 parasites were
transfected with pHH1-gdha-GFP and WR99210-resistant parasites
were analysed by fluorescence microscopy. GDHa-GFP (panel 1)
does not co-localize with the nucleus (Hoechst 33342 staining,
panel 2) nor with the mitochondrion (MitoTracker staining, panel 3).
From the merged image it is clear that GDHa is a cytosolic protein.
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Expression levels of proteins involved in antioxidant
reactions
In order to assess whether the absence of GDHa led to
changes in the expression of proteins involved in antiox-
idant defences, of which some are NADPH-dependent,
western blots of a variety of proteins were performed
(Figure 4). The protein levels of the cytosolic 2Cys-per-
oxiredoxin and 1Cys-peroxiredoxin, the cytosolic and
organellar superoxide dismutases 1 and 2, mitochondrial
isocitrate dehydrogenase, glutathione reductase and
cytosolic thioredoxin 1 did not change significantly in
D10Δgdh-1 and D10Δgdh-2 compared to wild type D10.
These results demonstrate that the parasites do not
respond to the absence of GDHa by elevating the
expression of their antioxidant protein repertoire, which
suggests that they are not under enhanced oxidative
stress. In addition, the transcript levels of gdhb, gdhc
and glucose-6-phosphate dehydrogenase, the major
source of NADPH in the parasite cytoplasm, were ana-
lysed by quantitative real time PCR. Similar to the
results described above, the mRNA levels of the three
genes appeared to be similar in all parasite lines tested.
The expression level of gdhb is two-fold up-regulated (p
< 0.05) in clone D10Δgdh-2 but whether this change
leads to an increase of GDHb protein remains to be
investigated when antibodies against this protein are
available (Table 2).
Analyses of glutathione levels
Apart from the parasite’s enzymatic antioxidant reper-
toire it is possible that the loss of GDHa function may
lead to changes in the level of the non-enzymatic anti-
oxidant and redox buffer glutathione (GSH). The ratio-
nale for this suggestion is that the intracellular
Figure 2 Generation of P. falciparum D10Δgdha as confirmed by Southern blot, western blot and enzymatic activity measurement. (A)
Schematic diagram of the endogenous gdha gene locus, the pHH1-Δgdha plasmid and the recombined gdha locus, following single cross-over
recombination between the plasmid and an 841 bp region of gdha (D10-Δgdha). The plasmid contains a human dihydrofolate reductase
(hDHFR) selectable marker under control of the P. falciparum calmodulin promoter (5’) and flanked by the P. falciparum histidine rich protein II 3’
UTR (3’), a region homologous to gdha (Δgdha) and an artificial 3’ UTR (P. berghei dihydrofolate reductase/thymidylate synthase 3’UTR, PbDT-3’).
NdeI restriction sites and sizes of the resulting diagnostic DNA fragments are indicated (in bold). (B) Southern blot of D10 wild type parasites
(lane 1), D10Δgdha (lane 2) and two D10Δgdha clones (lanes 3 and 4). The 5.3 kb endogenous gdha fragment is visible in the wild type and
D10Δgdha mixed population of parasites before cloning (lanes 1 and 2). In the latter, plasmid (5.8 kb) and the two integration fragments (7.2 kb
and 4.0 kb) are also detected. These fragments are still detected in the two clones, D10Δgdha-1 and D10Δgdha-2 (lanes 3 and 4). (C) Western blot
of D10, D10Δgdha-1 and D10Δgdha-2 protein extracts verifying the absence of GDHa (49 kDa) in D10Δgdha-1 and D10Δgdha-2. The protein reacting
non-specifically with the anti-GDHa antibody (~32 kDa) serves as a loading control. (D) Activity gel of D10, D10Δgdha-1 and D10Δgdha-2 protein
extracts showing GDHa activity in D10 only. Purified recombinant GDHa was included as control.
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concentration of GSH is tightly regulated by NADPH-
dependent glutathione reductase and decreased levels of
NADPH will affect the rate of glutathione disulphide
(GSSG) reduction, potentially resulting in a lower
amount of GSH and elevated levels of GSSG. The para-
sites are likely to respond to an increase in GSSG by
excreting the tripeptide [43-45] which may result in a
decrease in total GSH levels. However, the concentra-
tion of total GSH in D10Δgdh-1 and D10Δgdh-2, com-
pared to D10, was not significantly changed (831 ± 59
nmol/1010 cells; 536 ± 177 nmol/1010 cells and 677 ±
117 nmol/1010 cells in D10, D10Δgdh-1 and D10Δgdh-2,
respectively), suggesting that the reducing power in the
parasite was not affected by the absence of GDHa.
Concurrently, the mRNA levels of the two genes
involved in GSH biosynthesis, g-glutamylcysteine synthe-
tase (ggcs) and glutathione synthetase (gs) were deter-
mined and it was found that ggcs mRNA levels were
significantly increased between 2.1 and 2.8 fold in the
D10Δgdh clones compared to D10 (Table 2), but this
clearly does not lead to an increase in GSH.
Metabolic labelling and metabolite analyses
GDHa is thought to be of importance for the conversion
of L-glutamate to a-ketoglutarate and therefore instru-
mental to provide the carbon skeleton for the parasite’s
TCA pathway intermediates [46]. Synchronized D10,
D10Δgdh-1 and D10Δgdh-2 and non-infected red blood
cells were labelled with [U-13C] glutamine or [U-15N,U-
13C] glutamine for 32 hours to identify potential
changes in the metabolite composition of D10Δgdh-1 and
D10Δgdh-2. Metabolites were extracted and incorporation
of heavy isotopes was analysed by liquid chromatogra-
phy followed by mass spectrometry as previously
described [42,47].
The analyses showed that [U-13C] glutamine was con-
verted into glutamate and subsequently into a-ketoglu-
tarate, which was then converted into succinate (Table
3). Small amounts of +3 and +4 [13C] malate and +3
and +4 [13C] fumarate were also detected in the para-
sites. These results are in agreement with those pre-
viously reported by Olszewski et al [42]. Surprisingly,
the [13C] incorporation into a-ketoglutarate and the
other TCA pathway intermediates was similar in
D10Δgdh-1 and D10Δgdh-2 compared to D10. These data
strongly suggest that GDHa is either not, or not solely,
responsible for the conversion of L-glutamate into a-
ketoglutarate in the parasites and thus is not essential
for providing the carbon skeleton for TCA metabolism.
This clearly indicates that this crucial reaction is cata-
lysed by either one of the other two GDH proteins or
alternatively by aminotransferases, which are responsible
for the transfer of the amino group from glutamate and,
depending on the acceptor, results in the production of
aspartate, alanine or ornithine [48,49]. This was probed
by assessing the effect of L-cycloserine, an inhibitor of
aspartate and alanine aminotransferases [50,51].
Figure 3 Growth rate of P. falciparum D10 and D10Δgdhamutant
parasites Parasites were synchronized and 24 h later diluted to
0.5% parasitaemia (day 1). Thin blood smears were taken daily and
the parasite cultures were diluted 1:5 on day 2 and 4. The cultures
were maintained at either 1% oxygen (A) or 20% oxygen (B). The
experiment was performed in triplicate and the means ± S.D. are
shown.
Table 1 IC50 values for oxidative stress inducers and an aminotransferase inhibitor for D10 and D10
Δgdha clones
IC50 values (μM)
Parasite line N-methylphenazonium methosulfate Tert-butylhydroperoxide L-cycloserine
D10 0.8 ± 0.2 76.7 ± 20.0 145.8 ± 56.6
D10Δgdha-1 0.7 ± 0.2 81.8 ± 17.2 113.5 ± 37.5
D10Δgdha-2 0.7 ± 0.1 81.3 ± 15.5 111.9 ± 37.4
The effect on parasite viability by the endogenous stressor N-methylphenazonium methosulfate, the exogenous stressor tert-butylhydroperoxide and the
aminotransferase inhibitor L-cycloserine were determined by the incorporation of [3H]-hypoxanthine in the presence of increasing drug concentrations. The IC50
values were calculated by non linear regressing of the sigmoidal dose-response equation and shown are the mean ± S.D. of two (N-methylphenazonium
methosulfate) or three (tert-butylhydroperoxide) independent experiments. For L-cycloserine the mean ± S.E.M of six independent experiments is shown.
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However, there was no difference in IC50 values between
D10 wild type and the D10Δgdha clones suggesting that
these aminotransferases do not compensate for the loss
of GDHa function (Table 1). The lack of any significant
difference in incorporation of [15N] into amino acids of
wild type and mutant parasites after labelling with U-
[13C-15N]-glutamine further supports this notion (data
not shown).
Figure 4 Western blot analysis of P. falciparum proteins involved in antioxidant defence, redox balance or NADP(H) production. The
left panel shows representative western blots of D10, D10Δgdha-1 and D10Δgdha-2 protein extracts (10 μg) with a range of specific antibodies. The
loading control is shown underneath each blot and is either an antibody against the E2 subunit of branched chain a- ketoacid dehydrogenase
(50 kDa, panel A - G) or 2Cys- peroxiredoxin (25 kDa, panel H). The two panels on the right show the respective graphs (means ± S.D.) of the
densitometry analyses of two or three independent protein extracts. Relative protein levels were calculated by comparing the intensity of the
specific protein band with the loading control, with D10 set at 100% (cl1 is D10Δgdha-1 and cl2 is D10Δgdha-2). A) glutathione reductase (GR, 56
kDa), B) thioredoxin 1 (Trx, 12 kDa), C) blot B re-probed with glutathione S-transferase antiserum (GST, 25 kDa), D) superoxide dismutase 1 (SOD1,
22 kDa), E) superoxide dismutase 2 (SOD2, 22 kDa), F) 1Cys-peroxiredoxin (1Cys-Px, 25 kDa), G) 2Cys-peroxiredoxin (2Cys-Px, 25 kDa), H) isocitrate
dehydrogenase (IsoDH, 54 kDa).
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Discussion
The malaria parasite P. falciparum contains three genes
encoding potential glutamate dehydrogenases; two are
NADP(H)-dependent proteins while the cofactor specifi-
city of the third has not been determined to date [2,3]. A
previous study, using cross-reacting antibodies, suggested
that the parasites possess a cytosolic GDH protein with-
out distinguishing which of the three GDH proteins is
detected by the antibodies [52]. It was demonstrated here
that GDHa-GFP, expressed episomally in P. falciparum,
localizes exclusively to the parasite’s cytosol while there
is no GFP fluorescence present in the mitochondrion or
the apicoplast. This is an unusual situation given that in
mammals, plants and yeast, GDH are mitochondrial pro-
teins [1,5,53]. However, the localization of GDH can
change in senescence in plants, where the protein is dis-
tributed in organelle and cytosol [54].
The NAD(H)-dependent plant GDH and the mamma-
lian GDH (using either NAD(H) or NADP(H) as co-fac-
tor) are responsible for the oxidative deamination of
glutamate to provide a-ketoglutarate as TCA cycle
intermediate [1,6,7,53]. The NADP(H)-dependent plant,
yeast and bacterial enzymes catalyse the formation of
glutamate by assimilating NH4
+ onto a-ketoglutarate
[5,6]. The Plasmodium GDHa is a NADP(H)-dependent
protein and its kinetic parameters suggest that it can
catalyse forward and reverse reactions. It has been
argued that the Km value for NH4
+, which is between 7
to 10 mM, is high suggesting that the enzyme is more
likely to catalyse the formation of a-ketoglutarate and
the concomitant generation of NADPH [13]. Conse-
quently it was proposed that the major role for GDHa
in P. falciparum is to provide NADPH for vital antioxi-
dant reactions and therefore it was deemed a potential
target for antimalarial drug design [3,13,14].
In this study, this hypothesis was tested by generating
a P. falciparum line which no longer contains GDHa
protein, by disrupting the gdha gene locus. The relative
importance of GDHa for overall GDH activity was
assessed by determining the enzyme activity in parasite
extracts generated from D10 and D10Δgdha-1 and
D10Δgdha -2. The NADPH-dependent reduction of a-
ketoglutarate in D10 was in good agreement with pre-
viously reported GDH activities (36.9 nmol/min/mg in
D10 versus 63.0 nmol/min/mg, [18]). This NADPH-
dependent GDH activity was no longer detectable in the
mutant parasite lines, suggesting that GDHa contributes
the majority of this GDH activity during intra-erythrocy-
tic parasite development and that the two other pro-
teins, GDHb and GDHc, are only playing a minor role
for the NADPH-dependent conversion of a-ketogluta-
rate to glutamate. The oxidative deamination of gluta-
mate was below detection limit in D10 wild type and
mutant parasite lines, suggesting that GDHa is only
marginally supportive of this reaction. This is supported
by Vander Jagt et al [18]. Surprisingly, the loss of GDHa
function had no negative effect on the growth of the
mutant D10Δgdha lines under normal culturing condi-
tions. Similarly, applying oxidative stress by either
increasing oxygen tension or exposing mutant parasites
to pro-oxidants did not result in a growth defect or a
change of IC50 values of tert-butylhydroperxoide and N-
methylphenazonium methosulfate. This may be attribu-
table to increased levels of antioxidant proteins in
D10Δgdha, which are up-regulated in response to the loss
of GDHa function. However, enzymes that are part of
the parasite’s antioxidant repertoire did not show any
alterations in their expression levels as assessed by wes-
tern blotting. At mRNA level, no change was detected
by real time PCR for the expression levels of gdhc, one
of the other two genes potentially encoding GDH, or g-
6-pdh, the enzyme likely to be responsible to provide
NADPH for antioxidant reactions. The gene encoding
GDHb was found to be up-regulated in clone D10Δgdha-
2, while the other gene that showed a marginal up-regu-
lation of expression in both D10Δgdha clones was ggcs,
the rate limiting enzyme of GSH biosynthesis; however
no concomitant increase in GSH levels in D10Δgdha was
detectable. Together these data suggest that GDHa has
no obvious role in the defence against elevated levels of
oxidative stress and that providing NADPH for redox
reactions is unlikely to be its major role.
Table 2 Quantitative real time PCR of relevant genes
from D10 and D10Δgdha clones
Fold increase of mRNA compared to D10
Parasite line g6pdh gdhb gdhc gs ggcs
D10Δgdha-1 1.8 ± 0.7 1.6 ± 0.2 1.4 ± 0.3 1.4 ± 0.3 2.1 ± 0.2*
D10Δgdha-2 2.4 ± 1.0 2.2 ± 0.3* 1.7 ± 0.3 1.5 ± 0.4 2.8 ± 0.2*
The amount of mRNA was calculated using seryl-t-RNA synthase as
endogenous control and normalized to the amount of mRNA in D10. The
values are the mean ± S.D. of two independent experiments. * denotes a
significant difference in expression level compared to D10 (p < 0.05).
Table 3 Metabolic labelling resulting from growth of D10
and D10Δgdha clones with U-[13C] glutamine-containing
medium
Percentage incorporation of [13C]
Parasite
line
+5-[13C]
glutamate
+5-[13C] a-
ketoglutarate
+4-[13C]
succinate
rbc 60.5 ± 1.1 0 4.9 ± 1.4
D10 48.8 ± 1.8 47.1 ± 3.4 41.6 ± 3.0
D10Δgdha-1 45.9 ± 0.8 49.7 ± 4.1 39.9 ± 2.6
D10Δgdha-2 45.9 ± 0.6 53.0 ± 3.3 33.4 ± 5.5
The parasite lines were cultured for 32 h with medium containing 2 mM U-
[13C] glutamine and metabolites extracted and analysed by LC-MS. The
percentage of metabolite which has [13C] incorporated is shown. The values
are the mean ± S.D. of three independent experiments, which were done in
triplicate.
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The second reaction product of the oxidative deami-
nation of glutamate by GDHa is a-ketoglutarate, an
intermediate of the P. falciparum TCA pathway [42,46].
However, the metabolic labelling experiments performed
in this study show no difference in the incorporation of
the carbon skeleton of [13C] labelled glutamine into a-
ketoglutarate, succinate and other TCA pathway inter-
mediates between wild type and mutant parasites. This
implies that either GDHa is not involved in the oxida-
tive deamination of glutamate or that an alternative
pathway compensates for the loss of GDHa function.
The latter could be achieved by the two remaining
GDH proteins although their mRNA expression levels
appear only marginally changed upon gdha disruption.
However, it is possible that their catalytic activities are
elevated in the mutant parasites in response to meta-
bolic changes occurring as a consequence of the absence
of GDHa. The activity of GDH, from mammals to bac-
teria, is highly regulated by the availability of nitrogen
and carbon sources [1] suggesting that this may also be
possible in the malaria parasites. Clearly the parasites
are able to remove toxic ammonia through an efficient
aquaglyceroporin suggesting that considerable amounts
of the metabolic end-product of amino acid metabolism
can be dealt with to avoid intoxication [55].
Another possibility is that aminotransferases replace
GDHa function [48,49] but the susceptibility of
D10Δgdha parasites for the inhibitor L-cycloserine, acting
against aspartate and alanine aminotransferases [50,51],
was not altered compared to wild type parasites. Overall,
these data provide evidence that GDHa is not important
for the oxidative deamination of glutamate, but may
have a role in generating glutamate through NH4
+
assimilation.
Other organisms with multiple gdh genes have a clear
distinction between the catalytic activities of NADP(H)-
and NAD(H)-dependent enzymes. The NAD(H)- depen-
dent proteins catalyse the generation of a-ketoglutarate
while the NADP(H)-dependent GDH enzymes generate
glutamate [4-6,8,11]. Glutamate metabolism is highly
regulated and depends on the availability of carbon and
nitrogen sources. In bacteria it was shown that GDH is
only important for nitrogen assimilation when the con-
centration of NH4
+ is high and the bacteria are limited
for energy (for instance in glucose-limited medium)
[56,57]. Similarly, a NADP(H)-dependent GDH is
involved in NH4
+ assimilation in fungi, but only under
starvation conditions that limit the reactivity of the glu-
tamine synthetase/glutamate synthase cycle [58,59]. The
relatively high Km value for NH4
+determined for the
parasite GDHa suggests that it may function in a similar
way to the bacterial and fungal GDH and synthesizes
glutamate for nitrogen storage under starvation condi-
tions, which is supported by the finding that the
NADPH-dependent conversion of a-ketoglutarate into
glutamate is indeed lost in the mutant D10Δgdha lines.
Under normal growth conditions in bacteria and fungi,
glutamate is provided by glutamine synthetase and
NADP(H)-dependent glutamine:2-oxoglutarate amino-
transferase (glutamate synthase, GOGAT). Genes poten-
tially encoding both of these proteins are present in the
P. falciparum genome (PFI1110w: potential glutamine
synthetase; PF14_0334: potential GOGAT). P. falci-
parum is cultured in vitro in the presence of 2 mM glu-
tamine and 11 mM glucose supplying them with plenty
of nitrogen and carbon sources. In fact, the supply of
high concentrations of glutamine directly provides
GOGAT with the substrate it needs to produce gluta-
mate without the necessity to use glutamine synthetase,
which depends on ATP hydrolysis. This artificial in vitro
situation (high glutamine and glucose concentrations)
favours the glutamate production via GOGAT so that
the parasites do not rely on GDHa activity to synthesize
glutamate, explaining the lack of any obvious phenotype
of D10Δghda parasites.
This hypothesis raises important questions with
respect to the metabolic functions of GDH in Plasmo-
dium and needs further investigation. Clearly the roles
of GDHb and GDHc need to be examined concomi-
tantly to fully understand the significance of this inter-
esting metabolic pathway in the parasites. However,
these studies exclude a role of GDHa in antioxidant
defence and we conclude that GDHa during erythrocytic
development is not a suitable drug target given that the
protein may only be important for parasite survival
under limiting nutritional conditions.
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GDHa: glutamate dehydrogenase a; GDHb: glutamate dehydrogenase b;
GDHc: glutamate dehydrogenase c; GSH: glutathione; GSSG: glutathione
disulphide; RBC: red blood cell; TCA: tricarboxylic acid.
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